Why Is Perrigo (PRGO) Down 3.1% Since Last Earnings Report?

A month has gone by since the last earnings report for Perrigo (PRGO). Shares have lost about 3.1% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Perrigo due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.

How Have Estimates Been Moving Since Then?

It turns out, fresh estimates have trended downward during the past month.

The consensus estimate has shifted -5.22% due to these changes.

VGM Scores

At this time, Perrigo has a subpar Growth Score of D, a grade with the same score on the momentum front. However, the stock was allocated a grade of A on the value side, putting it in the top quintile for this investment strategy.

Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.

Outlook

Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Perrigo has a Zacks Rank #2 (Buy). We expect an above average return from the stock in the next few months.

Performance of an Industry Player

Perrigo is part of the Zacks Medical - Products industry. Over the past month, GE HealthCare Technologies (GEHC), a stock from the same industry, has gained 1.5%. The company reported its results for the quarter ended March 2025 more than a month ago.

GE HealthCare reported revenues of $4.78 billion in the last reported quarter, representing a year-over-year change of +2.7%. EPS of $1.01 for the same period compares with $0.90 a year ago.

For the current quarter, GE HealthCare is expected to post earnings of $0.91 per share, indicating a change of -9% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.

The overall direction and magnitude of estimate revisions translate into a Zacks Rank #4 (Sell) for GE HealthCare. Also, the stock has a VGM Score of C.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research